title: Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension.
authors.affiliation: Klinik III für Innere Medizin, Universität zu Köln, Köln, Germany.
authors.forename: Henrik
authors.initials: H
authors.lastname: ten Freyhaus
authors.forename: Daniel
authors.initials: D
authors.lastname: Dumitrescu
authors.forename: Henning
authors.initials: H
authors.lastname: Bovenschulte
authors.forename: Erland
authors.initials: E
authors.lastname: Erdmann
authors.forename: Stephan
authors.initials: S
authors.lastname: Rosenkranz
mesh_terms: D000818:Animals; D001549:Benzamides; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D000068877:Imatinib Mesylate; D008875:Middle Aged; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000150:complications*; D016896:Treatment Outcome; D018497:Ventricular Dysfunction, Right / Q000188:drug therapy / Q000209:etiology
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate